ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DCGO vs PIII // FREE CASH FLOW YIELD

DocGo Inc. (NASDAQ) VS. P3 Health Partners Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: DCGO 1 — PIII 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCGO VS. PIII) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DCGO PIII SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — — — TIE /fcf-yield <GO>
Operating Margin -55.30% -18.50% -36.80 PIII /operating-margins <GO>
Net Profit Margin -60.00% -10.10% -49.90 PIII /net-margins <GO>
Revenue Growth (YoY) -47.70% -2.80% -44.90 PIII /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 1/9 +4.00 DCGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.3 32.2 -0.94 PIII /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $27.0M $30.5M -$3.5M PIII /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DCGO REV PIII REV DCGO GROSS % PIII GROSS % DCGO FCF PIII FCF
FY 2025 $322.2M $1.46B — — $29.9M -$91.2M
FY 2024 $616.6M $1.50B — — $66.5M -$110.1M
FY 2023 $624.3M $1.27B — — -$64.5M -$76.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCGO // BETA —
PIII // BETA —